Pamela Scherer Mcleod from darkdaily.com wrote a very interesting article on how next-gen gene sequencing is affecting clinical research. Gene testing of patients enrolled in advanced cancer clinical trials may be able to supplement or even replace traditional enrolment. The reason for this is that next-generation gene sequencing is demonstrating that a “molecular triage” model for a clinical trial may increase effectiveness, reduce costs, and shorten development time. To read the full article click here.